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Abstract
Background: HIV susceptibility and pathogenicity exhibit both interindividual and intergroup variability. The
etiology of intergroup variability is still poorly understood, and could be partly linked to genetic differences among
racial/ethnic groups. These genetic differences may be traceable to different regimes of natural selection in the
60,000 years since the human radiation out of Africa. Here, we examine population differentiation and haplotype
patterns at several loci identified through genome-wide association studies on HIV-1 control, as determined by
viral-load setpoint, in European and African-American populations. We use genome-wide data from the Human
Genome Diversity Project, consisting of 53 world-wide populations, to compare measures of FST and relative
extended haplotype homozygosity (REHH) at these candidate loci to the rest of the respective chromosome.
Results: We find that the Europe-Middle East and Europe-South Asia pairwise FST in the most strongly associated
region are elevated compared to most pairwise comparisons with the sub-Saharan African group, which exhibit
very low FST. We also find genetic signatures of recent positive selection (higher REHH) at these associated regions
among all groups except for sub-Saharan Africans and Native Americans. This pattern is consistent with one in
which genetic differentiation, possibly due to diversifying/positive selection, occurred at these loci among
Eurasians.
Conclusions: These findings are concordant with those from earlier studies suggesting recent evolutionary change
at immunity-related genomic regions among Europeans, and shed light on the potential genetic and evolutionary
origin of population differences in HIV-1 control.
Background
HIV-1 infection is a global health problem and the
fourth leading cause of death worldwide [1]. One
approach to effective HIV prevention or treatment is to
understand the interplay of host molecular mechanisms
that are primarily influenced by genetic variation. Multi-
ple genes have been implicated as important genetic
determinants of the clinical course of HIV-1 infection
by regulating various biological pathways including
adaptive and innate immune responses [2]. However,
associations with most of these genes appear to be
population-specific, and many exhibit marked allele fre-
quency differences between different racial/ethnic
groups [3].
This interpopulation genomic variability and these dif-
ferential associations are still poorly understood, and
could plausibly be due to natural selection resulting
from distinct environmental or cultural pressures in dif-
ferent geographical populations [3]. For instance, the
most promising host genetic variant with biological and
functional significance in the control of HIV-1 infection
is a 32-bp deletion (CCR5-Δ32) in the CCR5 gene,
which codes for the b-chemokine receptor that the virus
uses to enter the host cells [2-5]. The homozygous dele-
tion of a 32-bp segment results in a nonfunctional
receptor [6], rendering individuals largely, but not com-
pletely, resistant to HIV-1 infection. The frequency of
homozygous deletion is < 1.5% among European-descent
populations, in which it has been postulated to have
arisen in response to immune challenges [5], is rare in
African Americans, and completely absent in African
and East Asian populations. Studies have also shown
evidence of positive selection at other genes involved in
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[7,8], while others do not find any such evidence [9].
Recent genome-wide association studies (GWAS) in
both European Americans (EA) and African Americans
(AA) have identified a region within the Human Leuko-
cyte Antigen (HLA) superlocus that is consistently asso-
ciated with HIV-1 viral load (VL) set-point, and which
seems to be the main predictor for disease progression
[10-13]. The two single nucleotide polymorphisms
(SNPs) with the strongest associations among EA,
rs2395029 and rs9264942, are located within 208 kilo-
bases (Kb) of each other in the HLA class I region of
chromosome 6, near the HCP5, HLA-B,a n dHLA-C
genes. Among AA, this is also the most strongly impli-
cated region of the HLA [13,14]. Among both AA and
EA, several non-HLA loci were also found to be among
the ‘top hits’ (i.e., lowest p-value) in GWAS. In fact, the
strongest associations in the GWAS among AA were
located outside the HLA region. Thus, if HLA variants
implicated in HIV-1 VL control show population differ-
ences and evidence of natural selection, one may expect
to observe similar patterns at the non-HLA variants that
have been implicated in HIV-1 VL control.
While the HIV-1 virus is known to adapt itself in
humans with staggering mutation rates, especially in
response to therapy, factors such as the very short time
since the emergence of the recent HIV-1 epidemic make
it unlikely that selection in humans in response to this
specific epidemic has exerted a large, detectable effect
[15]. It is however possible that these loci were subject
to natural selection in the more distant past in response
to other pathogens, and this has contributed to the
population differences we currently observe in HIV-1
VL control. We therefore hypothesize that the genomic
regions most strongly associated with HIV-1 VL control
in GWAS have been subject to natural selection and dif-
ferentiation in some populations. In order to test this
hypothesis, we examined patterns of FST and relative
extended haplotype homozygosity (REHH) in the geno-
mic regions surrounding both the HLA and non-HLA
HIV-1 control-associated loci identified through GWAS
in EA and AA. We find evidence of natural selection
among Eurasian groups at these loci.
Results
FST analysis
We first analyzed FST at the loci with the strongest evi-
dence of association among EA (rs2395029 and
rs9264942 in the HLA locus; see Table 1). The region
surrounding these two loci, which are in low LD (r
2 =
0.06, D’ = 0.86) in a EA population [11], exhibits very
low FST compared to random regions of chromosome 6
for all of the pairwise comparisons with sub-Saharan
Africans (AFR), suggesting that much less differentiation
than expected has occurred between AFR and other
groups (see Figure 1). However, the pairwise compari-
sons with Europeans (EUR) show that the extent of dif-
ferentiation between EUR and Middle Easterners (MID)
is substantially elevated, as it is between South Asians
(SAS) and EUR, compared to the comparisons with
AFR. Our bootstrap analysis shows that the FST of AFR-
Table 1 List of HLA and non-HLA SNPs from the Fellay et
al. [11] ‘top hits’ among European Americans (EA) and
the Pelak et al. [13] ‘top hits’ among African Americans
(AA) examined in this study.
Chromosome Position in
bases
Nearest
Gene
HLA SNPs - EA
rs2395029 6 31,539,759 HCP5
rs9264942 6 31,332,359 HLA-C
rs259919 6 30,133,482 ZNRD1
rs9468692 6 30,227,869 TRIM40
rs9266409 6 31,444,547 HLA-B
rs8192591 6 32,293,774 NOTCH4
HLA SNPs - AA
rs2523608 6 31,430,538 HLA-B
rs34548063 6 32,047,802 STK19,
DOM3Z
rs2523933 6 30,040,271 HLA-A, HCG9
rs2844538 6 31,456,858 HLA-B
rs2596503 6 31,428,789 HLA-B
Non-HLA SNPs - EA
rs12185555 2 227,559,317 IRS1
rs12557137 X 31,348,807 DMD
rs9677779 2 71,903,036 DYSF
rs11800642 1 212,909,744 NSL1
rs3735118 7 2,944,317 CARD11
rs7904001 10 66,762,723 None within
1M b
rs16959323 17 10,006,097 GAS7
rs5954635 X 141,450,842 MAGEC2
rs10073652 5 12,786,980 None within
1M b
rs6640729 X 11,346,716 ARHGAP6
Non-HLA SNPs - AA
rs454422 20 5,891,693 MCM8
rs6948404 7 36,577,018 AOAH
rs558718 19 7,815,883 EVI5L
rs1357339 11 80,532,023 None within
1M b
rs1413191 13 92,011,477 GPC5
rs2593321 3 22,097,400 ZNF659
rs1116084 8 22,406,934 PPP3CC
rs2789066 6 121,141,836 C6orf170
rs430374 18 42,499,453 ST8SIA5
rs11652146 17 44,774,660 ZNF652
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Page 2 of 11EUR is significantly lower (p < 0.001, and asymptotically,
p < 3.8 × 10
-12)t h a nt h eF ST of MID-EUR, SAS-EUR,
and AME-EUR, after considering the chromosomal
background differences.
We next examined whether this pattern of population
differentiation applies to the wider region of the HLA
that contains four additional independently associated
loci among EA, and the top five ‘hits’ in the HLA among
AA (see Table 1, and top two panels in Figure 2). For
most of this region we observe a similar pattern of very
little differentiation between AFR and other groups and
greater differentiation among EUR, MID, and SAS, as
well as Oceanians (OCE). Next, we examined the entire
HLA region, and find that this pattern of very little differ-
entiation between AFR and other groups applies specifi-
cally to the region containing the loci associated with
HIV-1 VL control, and is therefore not generalizable to
t h ee n t i r eH L A .A ss h o w ni nF i g u r e3 ,t h i sp a t t e r n
applies approximately to the 31 Mb to 32 Mb region of
chromosome 6, which is the region containing variants
associated with HIV-1 VL control
In order to investigate the finer-grained patterns of
differentiation among all 53 populations, we focused on
the 400 Kb genomic window surrounding rs2395029. As
shown in the above analyses, this region exhibits very
little differentiation between AFR groups and other
groups. However, within AFR, the degree of differentia-
tion appears to be quite elevated among the Bantu,
Mandenka, and Yoruba. We observe the greatest degree
of differentiation among the Makrani, Sindhi (SAS), and
the Druze (MID) populations (see Figure 4).
FST results for the mean of the top 10 non-HLA ‘hits’
for each of the EA and AA GWAS (see Table 1) are
s h o w ni nF i g u r e5 .W ef i n dap a t t e r no fd i f f e r e n t i a t i o n
for the AA loci similar to that found for the HLA loci
in that the group-specific FST (GSFST) appears to be
lower compared to that of other groups. However, this
difference is not statistically significant since the 95% CI
for the AFR GSFST overlaps with that of other groups.
Results for individual loci are shown in Additional Files
1 and 2. Among the AA ‘top hits’, the region surround-
ing rs1357339, a SNP in an intergenic region on Chro-
mosome 11, is much less differentiated between AFR
and other groups compared to the differentiation among
non-AFR. We observe a similar pattern at rs430374
near the ST8SIA5 gene on chromosome 18, and at
rs9910853 in the ZNF652 gene on Chromosome 17. In
all of our analyses, we obtained very similar results
using cM as opposed to Kb.
REHH
Depending on population group, among the 27,300 -
42,400 total haplotype cores across chromosome 6, we
examined between 346 and 520 haplotype cores in the
region delimited by 200 Kb upstream of rs9264942 and
200 Kb downstream of rs2395029. The number of >99
th
percentile REHH values within this region are shown in
T a b l e2 .W ef i n da ne x c e s so fe x t r e m eR E H Hv a l u e s
among SAS, MID, and East Asians (EAS) compared to
AFR and Native Americans (AME). This excess is statis-
tically significant (p < 0.0017) for all pairwise compari-
sons with AFR and AME, except for EUR and OCE. Q-
Q plots (Additional file 3) also show the excess of
lower-than-expected p-values among SAS, EAS, and
MID, compared to the other groups. We also examined
REHH values for haplotypes extending to 150 Kb, and
found a similar pattern. We find a similar pattern when
using only part of chromosome 6 containing the HLA,
instead of the entire chromosome, as the empirical dis-
tribution. The lowest panel in Figure 3 shows the loca-
tion of haplotypes with REHH p-values less than 0.005
for each group, except AFR and AME, for which there
are no qualifying haplotypes. Many of these haplotypes
are located around rs2395029, thus providing confirma-
tory evidence (based on both allele frequency differen-
tiation and haplotype length) for recent selection at
these loci in the MID, EUR and SAS and EAS groups.
We observe an upward trend in FST for the pairwise
comparison at the same location where we observe
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Figure 1 Pairwise FST percentile in relation to random regions
on chromosome 6 at rs2395029 (HCP5) with expanding
window size (50 Kb to 1600 Kb) for all AFR pairwise
comparisons (panel A) and all EUR pairwise comparisons
(panel B), and for rs9264942 (HLA-C) for all AFR pairwise
comparisons (panel C) and all EUR pairwise comparisons (panel
D). (AFR: sub-Saharan Africa; MID: Middle East; SAS: South Asia; EUR:
Europe; EAS: East Asia; OCE: Oceania; AME: Americas)
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Page 3 of 11evidence of extreme REHH for a given group. This is
e s p e c i a l l ya p p a r e n tf o rM I D ,S A S ,E A S ,a n dE U R .
REHH results for the non-HLA ‘top hits’ are shown in
Tables 3 and 4. We find no evidence of major differ-
ences among groups in the number of loci exhibiting
high REHH values.
Finally, we sought to determine whether the susceptibil-
ity or the protective allele for rs2395029 and rs9264942
is contained in the core of the haplotypes (with fre-
quency greater than 5%) that are outliers in the REHH
distribution (p < 0.05). We find no qualifying haplotypes
containing either of these SNPs among AFR and MID.
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Figure 2 Sliding window analysis (400 Kb window with 200 Kb overlapping) of FST percentile in relation to random regions on
chromosome 6 for all AFR pairwise comparisons (top panel) and for all EUR pairwise comparisons (middle panel). The lower panel
shows all haplotypes in region with REHH p < 0.005, and core frequency greater than 5%, for each group. Thickness of lines is weighted by core
haplotype frequency. AFR and AME are not shown in the lower panel because these groups had no qualifying haplotypes. Loci associated with
HIV-1 VL set-point are shown as vertical lines (solid for EA, dotted for AA). Locations of genes of interest are shown in the top of the figure. (AFR:
sub-Saharan Africa; MID: Middle East; SAS: South Asia; EUR: Europe; EAS: East Asia; OCE: Oceania; AME: Americas)
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Page 4 of 11Among SAS, we find that the susceptibility allele (T)
for rs2395029 is the allele which is in the core of a
haplotype with high REHH (p = 0.0015 and p =
0.0022, in either direction, frequency = 22.5%). This
haplotype contains approximately 23% of the suscept-
ibility alleles at this locus present among SAS. Among
E U R ,t h ep r o t e c t i v ea l l e l e( G )i si nt h ec o r eo fah a p l o -
type with high REHH (p = 0.0029 and p = 0.032 in
either direction, frequency = 5.4%). This haplotype
contains all protective alleles at this locus present
among EUR. Among EAS, the susceptibility allele of
rs2395029 is on a high-REHH haplotype (p = 0.0089
and p = 0.046 in either direction, frequency of 18%).
This haplotype contains approximately 10% of the sus-
ceptibility alleles at this locus present among EAS. The
protective allele (C) of rs9264942 is on a high REHH
haplotype (p = 0.024, frequency = 9%). This haplotype
contains approximately 21% of the protective alleles at
this locus present among EAS. Among OCE, the sus-
ceptibility allele of rs2395029 is on a high-REHH hap-
lotype (p = 0.028 and p = 0.044, frequency = 30% and
14%, respectively). Since the susceptibility allele is
fixed among OCE, these haplotypes contain approxi-
mately 30% and 14% respectively, of the susceptibility
alleles at this locus among OCE. We find no qualifying
haplotypes among AME.
Discussion
We hypothesized that the genetic variants found to be
associated with HIV-1 VL control were subject to recent
natural selection and population differentiation. This
natural selection could have resulted in the observed
population differences in HIV-1 pathogenicity among
contemporary populations. We examined the most sig-
nificant HLA and non-HLA variants associated with
HIV-1 VL in GWAS among EA and AA, and found that
the top associated loci in the HLA region are located in
a sub-region of the HLA that shows very little relative
differentiation between the considered sub-Saharan Afri-
can group and other groups, compared to the relative
levels of differentiation among the Eurasian groups con-
sidered. We also confirm that the patterns observed in
this sub-region are not generalizable across all HLA
sub-regions.
Considering all 53 populations, we find the greatest
degree of differentiation at the rs2395029 locus for
many pairwise comparisons with the Makrani and
Sindhi in Pakistan, as well as the Bantu in Africa, and
the Druze in Israel. Further studies are needed to con-
firm and gain a better understanding of the possible rea-
sons for this pattern. Although we take into account a
total of 253 SNPs in this locus, these results should be
interpreted with some caution given the small sample
sizes for some populations.
We find that the differentiation pattern observed in
the HLA sub-region also applies to the non-HLA ‘top
hits’, but only among those identified in the HIV-1 VL
GWAS among AA. Averaging GSFST over the top ten
regions shows a general trend of a smaller degree of dif-
ferentiation between the sub-Saharan African group and
other groups. The lack of differentiation that we observe
between the sub-Saharan African and other groups at
t h eH L As u b - r e g i o nc o u l db ed u et oah i g hd e g r e eo f
conservation. It is plausible that as each population in
Eurasia was subjected to unique selection pressures, a
greater degree of differentiation occurred among Eura-
sian groups than between each of these groups and sub-
Saharan Africans. These results should be interpreted
with caution because some of the ‘top hits’ that we
examine do not reach genome-wide statistical signifi-
cance in the respective GWAS.
Paralleling the pattern in differentiation, we observed
evidence of extreme relative extended haplotype homo-
zygosity (REHH) among Eurasian groups but not among
sub-Saharan Africans or Native Americans. On the basis
of our finding of multiple haplotypes with extreme
REHH and at relatively low frequencies (i.e. all below
37%), our results appear to be more consistent with a
mode of recent evolution characterized by multiple soft
sweeps as opposed to single hard sweeps [16].They also
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Figure 3 Sliding window analysis of FST percentile for a wider
view of the entire HLA region showing that the low FST for
AFR doesn’t apply everywhere in the HLA but mainly to the
region where the HIV associated loci are 31-32 Mb. Vertical lines
indicate location of rs2395029 and rs9264942. (AFR: sub-Saharan
Africa; MID: Middle East; SAS: South Asia; EUR: Europe; EAS: East Asia;
OCE: Oceania; AME: Americas)
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Page 5 of 11suggest that the patterns of differentiation and REHH
are not uniform and homogenous across all Eurasians.
Instead, it is possible that population-specific patterns of
genetic change, perhaps in response to region-specific
selection pressures, resulted in unique localized adapta-
tions in different Eurasian populations. Our REHH
Figure 5 A) Mean GSFST of top ten non-HLA ‘hits’ in GWAS
among European Americans, and B) Mean GSFST of top ten
non-HLA ‘hits’ in GWAS among African Americans. A. (AFR: sub-
Saharan Africa; MID: Middle East; SAS: South Asia; EUR: Europe; EAS:
East Asia; OCE: Oceania; AME: Americas)
Table 2 Number of extreme (p < 0.01) REHH values in
the 31,112,359 to 31,739,759 base region on
chromosome 6 for haplotypes extending to 300 Kb and
150 Kb from core.
Region AFR MID SAS EUR EAS OCE AME
Chrom. 6 - 300 Kb 0 12 (1) 24 (8) 3 21(6) 4 0
Chrom. 6 - 150 Kb 1 18 (6) 23 (3) 5 (1) 21 (3) 2 2 (1)
HLA - 300 Kb 0 13 (2) 17 (5) 3 8 (1) 2 0
Shown in parentheses are the number of haplotypes with p-value less than
0.001 (>99.9
th percentile). Also shown is the REHH when using the HLA region
as the empirical distribution as opposed to the entire chromosome. (AFR: sub-
Saharan Africa; MID: Middle East; SAS: South Asia; EUR: Europe; EAS: East Asia;
OCE: Oceania; AME: Americas)
Figure 4 Pairwise FST matrix for all 53 populations for the 400 Kb region surrounding rs2395029 compared to the rest of the
chromosome. Extremely high FST values from 0.9 to 1.0 are shown in shades of green, where the darkest green represents the 100
th percentile
and the lightest green represents the 90
th -9 5
th percentile. Extremely low FST values are shown in shades of red, where the darkest red
represents the 0
th percentile and the lightest red represents the 5
th -1 0
th percentile. (AFR: sub-Saharan Africa; MID: Middle East; SAS: South Asia;
EUR: Europe; EAS: East Asia; OCE: Oceania; AME: Americas)
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Page 6 of 11results suggest that the evidence for selection in the
HLA among Eurasian groups is one in which several dif-
ferent haplotypes of low to moderate frequency have
spread through populations. In this context, it should be
noted that REHH may not be powerful enough to detect
very low frequency haplotypes [17]. Other tests of selec-
tion such as XP-EHH (using the HGDP browser: http://
hgdp.uchicago.edu/cgi-bin/gbrowse/HGDP/) do not
appear to show similar trends as those we obtained
using FST a n dR E H H .T h i sm a yb ed u et ot h ef a c tt h a t
XP-EHH is most powerful for cases of selection in
which the selected haplotype reaches a very high fre-
quency in one population but not another, which does
not appear to be the situation for the loci that we have
examined.
Among Europeans in the HGDP, all rs2395029 protec-
tive alleles (G) are on a haplotype that has high REHH,
suggesting that this allele or one linked to it may have
quickly arisen in response to a selective pressure such as
an infectious disease in Europe. However, among South
Asians, East Asians and Oceanians, it is the susceptibil-
ity allele at this SNP that is the allele present on the
haplotype that has high REHH. The inconsistency of
these results could signify, among several things, that
there are many different polymorphisms in this region
that could have functional significance, that the genetic
basis of adaptation to similar pressures could be differ-
ent among different groups, and finally, that the genetic
basis of HIV-1 control could be different among differ-
ent racial/ethnic groups.
Our findings are consistent with recent findings that
signatures of selection among Europeans are enriched
for immunity related genes in the HLA [18,19]. In fact,
Kudaravalli et al. [20] recently found that SNPs asso-
ciated with gene expression levels of HLA-C also show
evidence of selection in both Europeans and East Asians
in the HapMap samples. Along with these and other
studies (see [21]), our findings suggest the presence of
Table 3 Summary of extreme REHH in 200 Kb regions surrounding non-HLA ‘top hits’ in EA GWAS.
AFR MID SAS EUR EAS OCE AME Total groups Total haplotypes
rs12185555 1112004 5 9
rs12557137 0 6 11 1 2 0 0 4 20
rs9677779 0020110 3 4
rs11800642 0003203 3 8
rs3735118 0120003 3 6
rs7904001 0000000 0 0
rs16959323 0100214 4 8
rs5954635 1113100 5 7
rs10073652 0000000 0 0
rs6640729 1200000 2 3
Total haplotypes 31 2 1 798 21 4
Total loci 3654524
Listed is the number of haplotypes with REHH empirical p-value less than 0.01 and core haplotype frequency greater than 5%. (AFR: sub-Saharan Africa; MID:
Middle East; SAS: South Asia; EUR: Europe; EAS: East Asia; OCE: Oceania; AME: Americas)
Table 4 Summary of extreme REHH in 200 Kb regions surrounding non-HLA ‘top hits’ in AA GWAS
AFR MID SAS EUR EAS OCE AME Total groups Total haplotypes
rs12185555 1112004 5 9
rs12557137 0 6 11 1 2 0 0 4 20
rs9677779 0020110 3 4
rs11800642 0003203 3 8
rs3735118 0120003 3 6
rs7904001 0000000 0 0
rs16959323 0100214 4 8
rs5954635 1113100 5 7
rs10073652 0000000 0 0
rs6640729 1200000 2 3
Total haplotypes 31 2 1 798 21 4
Total loci 3654524
Listed is the number of haplotypes with REHH empirical p-value less than 0.01 and core haplotype frequency greater than 5%. (AFR: sub-Saharan Africa; MID:
Middle East; SAS: South Asia; EUR: Europe; EAS: East Asia; OCE: Oceania; AME: Americas)
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Page 7 of 11selection pressures on the immune system, possibly
due to geographic, demographic, cultural, or environ-
mental factors related to subsistence. For example, our
fine-scaled analysis of all 53 HGDP populations shows
that among the sub-Saharan populations, those popula-
tions that show elevated FST between each other
(Bantu, Mandenka, and Yoruba) are also the groups
that have a history of practicing agriculture. It should
be noted that we have not examined populations from
E a s tA f r i c a ,a st h e s em a ys h o wv e r yu n i q u ep a t t e r n s ,
especially considering that the frequency of the
rs2395029 protective allele among the Maasai in the
HapMap3 sample is quite elevated (14%), and that
Henn et al. have found that this allele is also at a rela-
tively high frequency among the Sandawe (17%) in
East Africa, and that it exhibits evidence of recent
selection in this group [22].
While we have found evidence suggesting the action
of natural selection on the genomic regions associated
with HIV-1 VL among Eurasian populations, one has to
be cautious in interpreting our results. Although in all
of our analyses, we have controlled for the genomic
background by comparing FST and REHH at the locus
of interest to a distribution of other loci on the respec-
tive chromosome, we have not necessarily directly tested
whether the patterns we observe are consistent with nat-
ural selection as opposed to more stochastic evolution-
ary forces such as genetic drift. Although it is difficult
to distinguish selection from drift with certainty, the
greater extended haplotype homozygosity among Eura-
sians coinciding with elevated differentiation among
these groups makes the situation we have outlined (i.e.
positive selection among Eurasians and balancing selec-
tion among some sub-Saharan Africans) more
compelling.
Conclusions
In conclusion, our results show that the HLA region, as
well as some of the non-HLA regions, that contain loci
associated with HIV-1 VL control among persons of
both European and African ancestry, appear to have
been subject to natural selection, resulting in population
differentiation among Eurasian groups, but not among
other groups. Future studies on different samples and/or
with different methods will be needed to confirm our
findings, and should examine more fine-scale patterns
both at the geographic and genetic level. Understanding
the genome-wide selection pressure on HIV-1-interact-
ing proteins can provide insights into the evolutionary
dynamics of host factors, the genetic basis of differences
between nonpathogenic and pathogenic lentivirus infec-
tion, and the roles of individual genes in host-pathogen
interaction and immunopathogenesis.
Methods
HGDP populations and genotypes
W eu s e dt h ep u b l i c l ya v a i l a b l ed a t af r o mt h eH u m a n
Genome Diversity Project (HGDP) collection of 938
individuals from 53 different populations, genotyped at
over 650,000 SNPs on the Illumina 650Y platform, and
phased using fastPHASE [23]. Following recent reports
[24,25] we grouped the 53 populations into seven
broader groups based on geographical regions: Sub-
Saharan Africa (AFR; n = 102), Middle East (MID; n =
160), South Asia (SAS; n = 200), Europe (EUR; n =
156), East Asia (EAS; n = 229), Oceania (OCE; n = 28),
and America (AME; n = 63). A listing of the populations
in each group can be found in Additional file 4.
HIV-1-associated loci from GWAS studies
The set of loci examined in this study (see Table 1) was
determined from two HIV-1 GWAS, one performed in
European Americans (EA) [11], and the other in African
Americans (AA) [13]. In EA, the most strongly asso-
ciated variants were located in the HLA region of chro-
mosome 6. In AA, the most strongly associated variants
were located in various parts of the genome, including
t h es a m eH L Ar e g i o nf o u n di nE A .W ec h o s et h et o p2
‘hits’ (according to p-value) in the EA study (rs2395029,
rs9264942). We also examined four other independent
associations in the HLA region (rs259919, rs9468692,
rs9266409, rs8192591) reported in the EA study, and
the top five HLA ‘hits’ in the AA study. We also exam-
ined the top ten non-HLA ‘hits’ in each of the two stu-
dies. Among these top ten ‘hits’, we only considered the
SNP with the lowest p-value if more than one in the
same genomic region made the list.
FST
The FST statistic partitions the total genetic variance
into within- and between- population components,
thereby quantifying the extent of population differentia-
tion [26]. An elevated FST at a given locus relative to
the rest of the genome indicates a high degree of differ-
entiation among populations, which may be indicative of
positive selection, while a low FST is consistent with bal-
ancing or purifying selection, for example in highly con-
served regions of the genome. Since individual SNP-
based estimates of FST a r eh i g h l yv a r i a b l ea n dm a y
t h e r e f o r eb eu n r e l i a b l ei n d i c ators of differentiation at a
genomic locus [27,28], we calculated an average of FST
values for all SNPs contained in varying window sizes,
from 50 Kb to 1.6 Mb ("zooming out” by a factor of
two), each centered on the HIV-1-associated SNP.
Given that we are interested in relatively recent selec-
tion events, a window-based estimate of FST allows us to
detect the hitchhiking of loci near the putatively selected
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seems preferable since an associated variant detected by
GWAS may not represent the actual causal variant, but
instead a proxy for a nearby variant. In order to account
for variation in recombination patterns along the gen-
ome, we also perform the FST analyses using cM dis-
tance instead of Kb distance. We used the hg18/build
36 genetic map, retrieved from http://hgdp.uchicago.
edu/Browser_tracks/Genetic_Maps/.
To calculate FST, we used the method of Weir and
Cockerham [29]. We calculated a single global estimate
of FST (based on all 7 population groups), as well as all
21 pairwise estimates of FST.F ST was not calculated for
a SNP if that SNP is monomorphic in the groups being
compared. Negative values of FST were given a value of
0 because negative values are biologically meaningless.
To control for population-specific demographic effects
on the genome, we compared the FST in the risk win-
dow to a null distribution of FST values calculated in
randomly chosen windows. Specifically, for each risk
SNP, we randomly chose 1000 equally sized (in bp) win-
dows along the same chromosome, with similar genic/
non-genic content (± 10%), since FST tends to be slightly
higher for genic SNPs [30]. The genic/non-genic classifi-
cation was performed according to the annotation pro-
vided by Sullivan et al. (https://slep.unc.edu/evidence/?
tab=Downloads), which classifies a SNP based on
whether it is in the transcribed region of a gene. SNP
annotations were created using the TAMAL database
[31], based chiefly on UCSC genome browser files [32],
HapMap [33], and dbSNP [34].
For all 21 possible pairwise FST comparisons, we
obtained percentile ranks of the window centered on
the risk SNP, compared to the 1000 randomly centered
windows across chromosome 6, and use these to com-
pare differentiation of the risk-SNP window across
groups. However, in order to determine the significance
of the difference between the risk-SNP window FST
between populations A and B and the same risk-SNP
window FST between populations A and C, while con-
sidering the difference in null chromosomal background
(through the mean FST of 1000 randomly chosen win-
dows, excluding the risk-SNP window, as described
above), we generated 1000 bootstrap resamples from the
total sample of 938 individuals. For each of the boot-
strap resamples we calculated the risk-SNP window FST
and the mean FST of the 1000 random (non-risk) win-
dows. We then tested the null hypothesis that the differ-
ence in risk-SNP window FST i st h es a m ea st h e
difference for the mean of the random windows, formu-
lated as follows:
Ho : θX,A−B − θ– X,A−B = θX,A−C − θ– X,A−C,
where (θX, A-B)i st h eF ST for the risk window (X)
between population A and B, θX, A-C is the FST for the
risk window (X) between population A and C, θ– X,A−B is
the FST at regions other than the risk region X (– X)
between population A and B, and θ– X,A−B is the FST at
regions other than the risk region X (– X) between
population A and C. To do so, we assumed that the
sample estimators of the four θ’s utilized in the null
hypothesis stated above are asymptotically unbiased
estimators. Let us denote the sample estimators of the
population parameters by the use of a circumflex and
let: T = (ˆ θX,A−B − ˆ θX,A−B) = (ˆ θX,A−C − ˆ θX,A−C).U n d e rt h e
null hypothesis and the assumption that the estimators
are unbiased, E(T) = 0. Therefore, testing the null
hypothesis that E(T) = 0 is a valid test of the null sta-
ted above. In an ordinary sample of independent
observations (individuals) taken from the populations
of interest, one can test E(T) = 0 using bootstrap
methods. None of the above analyses depend on any of
the ˆ θs or any quantities on which they are based being
independent. The value of T from the observed sample
Tobs was calculated. One thousand bootstrap samples
were taken from the original sample with replacement,
and a value of T calculated in each bootstrap sample,
denoted T∗
i for the ith bootstrap sample. A p-value
to test the null hypothesis stated above was then
calculated in two ways, conservatively as
p 
1+
1000
i=1 I(|T∗
i − Tobs|  Tobs)
1000
, and asymptotically
by letting ˆ σTobs be the ordinary sample standard devia-
tion of the T*, and assuming that the

Tobs
ˆ σTobs
2
is
asymptotically distributed as c
2 with 1 df. Due to com-
putational limitations, we restricted this analysis to the
rs2395029 SNP.
Given that we are interested in examining the top ten
non-HLA variants as a set, as well as each one sepa-
rately, we averaged the 10 percentiles of all pairwise FST
comparisons. In order to obtain a group-specific FST for
a given group, which we refer to as GSFST,w ea v e r a g e d
the FST percentile ranks of the six pairwise comparisons
that contain the group in question. For example, to
obtain an estimate of GSFST for AFR, we took the aver-
age of the percentile FST of the following six pairwise
comparisons: AFR-MID, AFR-SAS, AFR-EUR, AFR-EAS,
AFR-OCE, and AFR-AME. Instead of considering many
pairwise comparisons for each locus, GSFST allows us to
examine how differentiated a given group is at a given
locus compared to all other groups, and relative to the
rest of the chromosome.
Because the associated loci in the HLA region were
clustered in a relatively small region, we examined the
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an overlap of 200 Kb, from 29.8 to 32.5 Mb on chro-
mosome 6. We also examined the entire HLA region
to determine if the pattern observed in the 29.8 to
32.5 Mb region is characteristic of the HLA region as
a whole (28 to 35.6 Mb). To investigate the level of
differentiation among all 53 populations, we con-
structed a matrix of FST percentiles for all possible
pairwise comparisons for the 400 Kb region surround-
ing rs2395029.
REHH
Extended haplotype homozygosity (EHH) is defined as
the probability that two randomly chosen chromo-
somes carrying the core haplotype of interest are
identical by descent, and the relative EHH (REHH) is
the factor by which EHH decays on the tested core
haplotype compared to that of other core haplotypes
combined [35]. The REHH thus corrects for local var-
iation in recombination rates. We obtained REHH
values using Sweep software v1.1 [35], (downloaded
from http://www.broadinstitute.org/mpg/sweep). For
all associated SNPs, we used the same phased haplo-
type data as above, and examined REHH at haplotypes
containing the HIV-1 risk SNP, and all haplotypes
contained in the surrounding 400 Kb region (200 Kb
in either direction). Core haplotypes were defined
according to the definition of a haplotype block in
Gabriel et al. [36], and REHH was measured 300 Kb
and 150 Kb away from the core haplotype. For each
region and each population group, we compared the
REHH in the risk SNP region to the entire chromo-
some on which the region resides, to determine if the
candidate region contains haplotypes with exception-
ally high REHH, binning by haplotype frequency. We
only considered core haplotypes with frequency
greater than 5%.
We examined REHH in the region surrounding both
the ‘top hits’ in the EA and AA study, and 200 Kb out-
ward in either direction, and noted all instances in
which a haplotype had a REHH value in the top 99.9
th,
99.5
th,9 9
th, and 95
th percentile of the empirical distribu-
tion, binning by haplotype frequency. We use Q-Q plots
to examine the distribution of observed vs. expected
-log10 p-values for the REHH values in this region, for
each of the population groups. For the wider HLA
region that encompasses other GWAS top ‘hits’, we con-
sidered all haplotypes from 29.8 to 32.5 Mb on chromo-
some 6. We use the entire chromosome 6, as well as the
entire HLA region as empirical distributions. We used a
two-sided Fisher’s exact test to determine whether there
is an excess of instances of extreme REHH in one or
more groups.
Additional material
Additional file 1: GSFST percentile for top ten non-HLA ‘hits’ among
African Americans. Window size (Kb) is on the x-axis while GSFST
percentile in on the y-axis, for windows centered on the top ten non-
HLA ‘hits’ in the African-American GWAS.
Additional file 2: GSFST percentile for top ten non-HLA ‘hits’ among
European Americans. Window size (Kb) is on the x-axis while GSFST
percentile in on the y-axis, for windows centered on the top ten non-
HLA ‘hits’ in the European-American GWAS.
Additional file 3: Q-Q plots of REHH p-values by group. Observed vs.
expected -log10 p-values for REHH in seven groups, considered in the
31.1. to 37.3 Mb region of chromosome 6. P-values are empirical, based
on the distribution of all REHH p-values for all of chromosome 6.
Additional File 4: Details of HGDP sample. A listing of the 53
populations in the HGDP sample and how they were grouped.
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